Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 5.1 Opinion of Gibson, Dunn & Crutcher LLP, Counsel of Cohbar, Inc
- 10.27 Exclusive License Agreement, Dated March 29, 2019, Between Morphogenesis, Inc. and H. Lee Moffitt Cancer and Research Institute, As Amended
- 10.28 Exclusive License Agreement, Dated April 23, 2021, Between Morphogenesis, Inc. and H. Lee Moffitt Cancer and Research Institute, As Amended
- 10.29 Restated and Amended Exclusive License Agreement, Dated September 7, 2022, Between Morphogene-sis, Inc. and West Virginia Research Corporation
- 10.30 Asset Purchase Agreement, Dated January 26, 2023, Between Tuhura Biopharma Inc. and Morphogenesis, Inc
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm of Cohbar, Inc
- 23.2 Consent of Cherry Bekaert LLP, Independent Registered Public Accounting Firm of Morphogenesis, Inc
- Download Excel data file
- View Excel data file
Associated filings
- 13 Sep 23 EFFECT Notice of effectiveness
- 12 Sep 23 424B3 Prospectus supplement
- 12 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
10 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 30 Jun 23 S-4 Registration of securities issued in business combination transactions
CWBR similar filings
Filing view
External links